Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 204

The DOI matches its Crossref record.

RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 IN OPEN TIBIAL FRACTURES: A SUBGROUP ANALYSIS OF DATA COMBINED FROM TWO PROSPECTIVE RANDOMIZED STUDIES

SWIONTKOWSKI, MARC F., ARO, HANNU T., DONELL, SIMON, ESTERHAI, JOHN L., GOULET, JAMES, JONES, ALAN, KREGOR, PHILIP J., NORDSLETTEN, LARS, PAIEMENT, GUY, PATEL, AMRATLAL·2006·The Journal of Bone and Joint Surgery-American Volume

Abstract

BACKGROUND: The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) to improve the healing of open tibial shaft fractures has been the focus of two prospective clinical studies. The objective of the current study was to perform a subgroup analysis of the combined data from these studies. METHODS: Two prospective, randomized clinical studies were conducted. A total of 510 patients with open tibial fractures were randomized to receive the control treatment (intramedullary nail fixation and routine soft-tissue management) or the control treatment and an absorbable collagen sponge impregnated with one of two concentrations of rhBMP-2. The rhBMP-2 implant was placed over the fracture at the time of definitive wound closure. For the purpose of this analysis, only the control treatment and the Food and Drug Administration-approved concentration of rhBMP-2 (1.50 mg/mL) were compared. Patients who anticipated receiving planned bone-grafting as part of a staged treatment were excluded from enrollment. RESULTS: Fifty-nine trauma centers in twelve countries participated, and patients were followed for twelve months postoperatively. Two subgroups were analyzed: (1) the 131 patients with a Gustilo-Anderson type-IIIA or IIIB open tibial fracture and (2) the 113 patients treated with reamed intramedullary nailing. The first subgroup demonstrated significant improvements in the rhBMP-2 group, with fewer bone-grafting procedures (p = 0.0005), fewer patients requiring invasive secondary interventions (p = 0.0065), and a lower rate of infection (p = 0.0234), compared with the control group. The second subgroup analysis of fractures treated with reamed intramedullary nailing demonstrated no significant difference between the control and the rhBMP-2 groups. CONCLUSIONS: The addition of rhBMP-2 to the treatment of type-III open tibial fractures can significantly reduce the frequency of bone-grafting procedures and other secondary interventions. This analysis establishes the clinical efficacy of rhBMP-2 combined with an absorbable collagen sponge implant for the treatment of these severe fractures.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2106/00004623-200606000-00013

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 204

Metadata

Authors
SWIONTKOWSKI, M. F., ARO, H. T., DONELL, S., ESTERHAI, J. L., GOULET, J., JONES, A., KREGOR, P. J., NORDSLETTEN, L., PAIEMENT, G., & PATEL, A.
Venue
The Journal of Bone and Joint Surgery-American Volume
Published
2006-06
Volume
88
Issue
6
Pages
1258-1265
ISSN
0021-9355 (ISSN-L)
OpenAlex
W1967491412
Cited by
204
References
0
FWCI
12.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 IN OPEN TIBIAL FRACTURES: A SUBGROUP ANALYSIS OF DATA COMBINED FROM TWO PROSPECTIVE RANDOMIZED STUDIES. https://app.cochat.ai/papers/10.2106/00004623-200606000-00013
The paper
SWIONTKOWSKI, M. F., ARO, H. T., DONELL, S., ESTERHAI, J. L., GOULET, J., JONES, A., KREGOR, P. J., NORDSLETTEN, L., PAIEMENT, G., & PATEL, A. (2006). RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 IN OPEN TIBIAL FRACTURES: A SUBGROUP ANALYSIS OF DATA COMBINED FROM TWO PROSPECTIVE RANDOMIZED STUDIES. The Journal of Bone and Joint Surgery-American Volume. https://doi.org/10.2106/00004623-200606000-00013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.